Drugs / KCCFPAQ-GGGSK-(5-FITC)-NH2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02156557 | Jun 2014 → Jul 2016 | colorectal cancer, inflammatory bowel disease, polyp of colon | Danielle Kim Turgeon | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KCCFPAQ-GGGSK-(5-FITC)-NH2 | “* KCCFPAQ-GGGSK-(5-FITC)-NH2 * 1.2 mg lyophilized powder per single-use amber vial” NCT02156557 ↗ |
| Route | Topical | “The entire 10 mL solution will be sprayed topically onto area of interest” NCT02156557 ↗ |